XJPX8938
Market cap39mUSD
Jan 16, Last price
689.00JPY
1D
-5.23%
1Q
4.87%
Jan 2017
-26.70%
IPO
-68.68%
Name
Glome Holdings Inc
Chart & Performance
P/E
—
P/S
5.04
EPS
—
Div Yield, %
0.72%
Shrs. gr., 5y
—
Rev. gr., 5y
4.17%
Revenues
1.24b
-31.15%
Net income
-198m
L
CFO
-187m
L
Dividend
Mar 28, 20250 JPY/sh
Profile
GLOME Holdings,Inc., together with its subsidiaries, engages in the medical-related and real estate businesses in Japan and internationally. It operates medical institutions; hospitals, including nursing care hospitals and facilities; elderly care and health care facilities; and clinics. The company also provides information related to health care, medical care, and welfare, as well as gold loans. In addition, it is involved in personnel and affairs center training; economic management; operational guidance; and informed career introduction activities. Further, the company provides support in medicine and medical equipment purchases, inventory management, food business, information technology, real estate facility management, establishing personnel system, and formulation of regulations. Additionally, it advises and provides guidance for business undertakings such as medical corporations, as well as leases commercial facilities. The company was formerly known as LC Holdings, Inc. and changed its name to GLOME Holdings,Inc. in October 2019. GLOME Holdings,Inc. was incorporated in 1987 and is headquartered in Tokyo, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | |
| Income | |||||
Revenues | 1,238,000 -31.15% | 1,798,000 -27.21% | 2,470,000 -36.73% | ||
Cost of revenue | 1,351,000 | 754,000 | 1,124,000 | ||
Unusual Expense (Income) | |||||
NOPBT | (113,000) | 1,044,000 | 1,346,000 | ||
NOPBT Margin | 58.06% | 54.49% | |||
Operating Taxes | 13,000 | 40,000 | 126,000 | ||
Tax Rate | 3.83% | 9.36% | |||
NOPAT | (126,000) | 1,004,000 | 1,220,000 | ||
Net income | (198,000) -156.90% | 348,000 67.31% | 208,000 -181.57% | ||
Dividends | (45,000) | (54,000) | |||
Dividend yield | 0.76% | 0.50% | |||
Proceeds from repurchase of equity | |||||
BB yield | |||||
| Debt | |||||
Debt current | 310,000 | ||||
Long-term debt | |||||
Deferred revenue | 425,000 | 1,242,000 | |||
Other long-term liabilities | 168,000 | (260,000) | (965,000) | ||
Net debt | (3,650,000) | (4,765,000) | (4,728,000) | ||
| Cash flow | |||||
Cash from operating activities | (187,000) | 755,000 | 196,000 | ||
CAPEX | (28,000) | (26,000) | (8,000) | ||
Cash from investing activities | 38,000 | 769,000 | (172,000) | ||
Cash from financing activities | (45,000) | (364,000) | (276,000) | ||
FCF | 958,000 | 954,000 | 1,700,000 | ||
| Balance | |||||
Cash | 2,769,000 | 2,964,000 | 1,848,000 | ||
Long term investments | 881,000 | 1,801,000 | 3,190,000 | ||
Excess cash | 3,588,100 | 4,675,100 | 4,914,500 | ||
Stockholders' equity | 4,756,000 | 3,827,000 | 6,148,000 | ||
Invested Capital | 4,347,900 | 4,305,000 | 3,206,500 | ||
ROIC | 26.73% | 30.37% | |||
ROCE | 12.84% | 16.57% | |||
| EV | |||||
Common stock shares outstanding | 9,050 | 9,050 | 9,050 | ||
Price | 652.00 -45.26% | 1,191.00 27.24% | 936.00 -41.39% | ||
Market cap | 5,900,855 -45.26% | 10,779,062 27.24% | 8,471,205 -19.31% | ||
EV | 2,250,855 | 4,848,062 | 5,245,205 | ||
EBITDA | (40,000) | 1,125,000 | 1,461,000 | ||
EV/EBITDA | 4.31 | 3.59 | |||
Interest | 2,000 | 5,000 | |||
Interest/NOPBT | 0.19% | 0.37% | |||